Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
SALES / VALUECompleted eBay sales; useful support, especially for the global market.
Transaction-based price; use it as the valuation baseline.
Transaction-based price; use it as the valuation baseline.
Seller asking prices. They show availability but do not prove demand.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-11-07 | Sold | €16.55 | — |
| 2026-11-07 | TCG | $10.64 | — |
| 2026-11-06 | Sold | €16.55 | +21.6% |
| 2026-11-06 | List | €20.00 | +0.1% |
| 2026-11-06 | TCG | $10.64 | -2.4% |
| 2026-11-06 | EB | $12.80 | +10.3% |
| 2026-11-05 | Sold | €13.61 | -0.5% |
| 2026-11-05 | TCG | $10.90 | +1.8% |
| 2026-11-05 | EB | $11.60 | -4.9% |
| 2026-11-04 | Sold | €13.68 | +0.1% |
| 2026-11-04 | TCG | $10.71 | -0.9% |
| 2026-11-04 | EB | $12.20 | -12.8% |
| 2026-11-03 | Sold | €13.67 | -2.3% |
| 2026-11-03 | TCG | $10.81 | +1.6% |
SV: Scarlet & Violet 151 / #180/165/Holofoil
Italy: lowest · United Kingdom: above average · EU average €19.34Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
NMRAW | $10.64 | $10.64 | $10.64 | +15.4% | >5 | |
LPRAW | $10.00 | $10.00 | $10.00 | +15.4% | >5 | |
AggregatedRAW | €16.55 | €7.00 | €86.66 | +15.4% | >5 | |
MPRAW | $12.18 | $12.18 | $12.18 | +15.4% | >5 | |
DMGRAW | $8.95 | $3.76 | $9.27 | +15.4% | >5 | |
HEAVILY PLAYEDRAW | $9.00 | $9.00 | $9.00 | +15.4% | >5 | |
MINTRAW | €12.00 | €9.99 | €24.00 | +15.4% | >5 |
Explore Omanyte #180/165, Holofoil from SV: Scarlet & Violet 151, with 2110 price records for the US market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.